Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

ClinicalTrials.gov ID: NCT00402168

Public ClinicalTrials.gov record NCT00402168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belatacept Conversion Trial in Renal Transplantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn if conversion to belatacept from cyclosporine or tacrolimus will preserve kidney function in people who have had a kidney transplant. The safety and tolerability of this treatment will also be studied

Study identification

NCT ID
NCT00402168
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
173 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
May 31, 2009
Completion
May 31, 2013
Last update posted
Jan 4, 2017

2007 – 2013

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054
National Institute Of Transplantation Los Angeles California 90057
California Institute Of Renal Research San Diego California 92123
Ucsf San Francisco California 94143-0106
University Of Chicago Chicago Illinois 60637
Pharmacy, First Call Iv Kenner Louisiana 70062
Tulane University Hospital & Clinic New Orleans Louisiana 70112
University Of North Carolina School Of Medicine Chapel Hill North Carolina 27599-7155
Medical College Of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

Recently updated Renal Transplant trials

Other public records listing Renal Transplant. Sorted by last update posted; newest first. Not a recommendation.

All Renal Transplant trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00402168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2017 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00402168 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →